PYC Therapeutics Limited ( (AU:PYC) ) has provided an update.
PYC Therapeutics Limited has launched a 1 for 4 accelerated non-renounceable pro-rata entitlement offer of fully paid ordinary shares, priced at $1.25 per share. This initiative is part of their strategy to strengthen their financial position and support future growth. The offer is accessible to eligible retail shareholders in Australia and New Zealand, while excluding the United States, reflecting the company’s focus on expanding its shareholder base within these regions.
More about PYC Therapeutics Limited
YTD Price Performance: -4.96%
Average Trading Volume: 428,521
Technical Sentiment Consensus Rating: Sell
Current Market Cap: A$726.2M
Find detailed analytics on PYC stock on TipRanks’ Stock Analysis page.
Trending Articles:
Questions or Comments about the article? Write to editor@tipranks.com